Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
1,847,113
-
Share change
-
-202,594
-
Total reported value
-
$285,150,847
-
Put/Call ratio
-
46%
-
Price per share
-
$154.38
-
Number of holders
-
106
-
Value change
-
-$31,401,828
-
Number of buys
-
31
-
Number of sells
-
48
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2017
As of 31 Dec 2017,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,847,113 shares.
The largest 10 holders included
Clal Insurance Enterprises Holdings Ltd, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, ARS Wealth Advisors, LLC, BROWN ADVISORY INC, ROYAL BANK OF CANADA, Mawer Investment Management Ltd., CITADEL ADVISORS LLC, AMERIPRISE FINANCIAL INC, and WELLS FARGO & COMPANY/MN.
This page lists
107
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.